LEXARIA BIOSCIENCE CORP. Subsidiaries
Every subsidiary the company listed in Exhibit 21 of its annual reports, newest list first (2 lists). Names and jurisdictions are as filed.
- 2024-11-26: Subsidiary 100% owned by Lexaria Bioscience Corp..
- 2024-11-26: Subsidiary Poviva Corp..
- 2024-11-26: Subsidiary Lexaria Nutraceutical Corp..
- 2024-11-26: Subsidiary Lexaria Hemp Corp..
| Annual report filed | Subsidiary | Jurisdiction |
|---|---|---|
| 2024-11-26 | 100% owned by Lexaria Bioscience Corp. | |
| 2024-11-26 | Poviva Corp. | |
| 2024-11-26 | Lexaria Nutraceutical Corp. | |
| 2024-11-26 | Lexaria Hemp Corp. | |
| 2024-11-26 | Lexaria Pharmaceutical Corp. | |
| 2024-11-26 | Lexaria (AU) Pty Ltd | |
| 2024-11-26 | Kelowna Management Services Corp. | |
| 2024-11-26 | Lexaria CanPharm Holding Corp. | |
| 2024-11-26 | 100% owned by Lexaria CanPharm Holding Corp. | |
| 2024-11-26 | Lexaria CanPharm ULC | |
| 2024-11-26 | 83.333% owned by Lexaria Bioscience Corp. | |
| 2024-11-26 | Lexaria Nicotine LLC | |
| 2021-11-29 | Lexaria CanPharm ULC, a British Columbia Canada unlimited liability corporation | |
| 2021-11-29 | PoViva Corp., a Nevada corporation | |
| 2021-11-29 | Lexaria Hemp Corp., a Delaware corporation | |
| 2021-11-29 | Lexaria Nicotine LLC, a Delaware limited liability corporation | |
| 2021-11-29 | Lexaria CanPharm Holding Corp., a Nevada corporation | |
| 2021-11-29 | Lexaria Pharmaceutical Corp., a Delaware corporation | |
| 2021-11-29 | Kelowna Management Services Corp., a British Columbia corporation |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |